- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07586527
Adapted Mindfulness Training for Diabetic Patients With Impaired Hypoglycemia Awareness
8 de mayo de 2026 actualizado por: Mengyao Han, Yangzhou University
Impact of Adapted Mindfulness Training Integrating Interoception on Diabetic Patients With Impaired Awareness of Hypoglycemia: A Randomized Controlled Trial
The purpose of this randomized controlled trial is to evaluate the effectiveness of an 8-week interoception-integrated adapted mindfulness training program for patients with type 1 or type 2 diabetes who experience impaired awareness of hypoglycemia (IAH).
The study aims to determine whether this mindfulness intervention, which includes techniques such as body scanning and mindful eating, can help patients better recognize early physiological signals of low blood sugar compared to routine care.
Researchers will measure changes in participants' interoceptive awareness and the severity of their IAH over a 3-month follow-up period.
The ultimate goal is to provide a practical psychological approach to improve symptom perception and reduce the risk of severe hypoglycemic events in diabetic patients.
Descripción general del estudio
Estado
Aún no reclutando
Condiciones
Intervención / Tratamiento
Descripción detallada
Diabetic patients are prone to hypoglycemia during insulin therapy, and repeated episodes can lead to impaired awareness of hypoglycemia (IAH), significantly increasing the incidence of severe hypoglycemia and adverse health outcomes.
Recent studies indicate that altered interoceptive awareness is closely associated with an increased risk of IAH, and mindfulness interventions can effectively enhance an individual's interoceptive awareness.
This study aims to explore the effects of an interoception-integrated adapted mindfulness training program on interoceptive awareness and impaired awareness of hypoglycemia in diabetic patients.
This study is a two-arm, parallel-group randomized controlled trial.
It plans to recruit 100 type 1 or type 2 diabetic patients with IAH who meet the eligibility criteria (e.g., Gold score ≥ 4 and Clarke score ≥ 4) from two community health centers in Yangzhou.
Participants will be randomly assigned in a 1:1 ratio to either the intervention group (n=50) or the control group (n=50).
The control group will receive routine treatment, examinations, nursing care, and health education.
On this basis, the intervention group will receive an 8-week interoception-integrated adapted mindfulness training program, conducted once a week (1-1.5 hours per session).
Based on Mindfulness-Based Stress Reduction (MBSR), the program utilizes core techniques such as body scanning, mindful eating, and mindful walking to reinforce patients' perception and awareness of early physiological signals of hypoglycemia, supplemented by daily home practices.
Primary outcomes are the patients' interoceptive awareness (assessed by the MAIA-2 scale) and the severity of impaired awareness of hypoglycemia (evaluated by the Clarke and Gold questionnaires).
Secondary outcomes include mindfulness levels (FFMQ) and negative cognitive processing bias (NCPBQ).
Data collection time points are set at pre-intervention (T0), immediately post-intervention (T1), 1 month post-intervention (T2), and 3 months post-intervention (T3).
Statistical analyses will employ descriptive statistics, univariate analysis, and Generalized Estimating Equations (GEE) to evaluate the intervention effects.
This study is expected to provide a practical psychological intervention to improve symptom perception in diabetic patients with IAH, thereby reducing the incidence of severe hypoglycemia and improving clinical outcomes.
Tipo de estudio
Intervencionista
Inscripción (Estimado)
100
Fase
- No aplica
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
No
Descripción
Inclusion Criteria:
- Diagnosed with type 1 or type 2 diabetes mellitus according to the latest American Diabetes Association (ADA) Standards of Care in Diabetes;
- Receiving insulin therapy for ≥ 1 year;
- Age between 18 and 80 years (inclusive);
- Duration of diabetes ≥ 5 years;
- Gold score ≥ 4 and Clarke score ≥ 4;
- Voluntary participation and provision of signed informed consent.
Exclusion Criteria:
- Prior experience with mindfulness interventions;
- Diagnosed with cognitive impairment, psychiatric disorders, or other severe physical comorbidities;
- Current use of psychotropic medications;
- Pregnant or lactating women, or women of childbearing potential not using effective contraception.
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Cuidados de apoyo
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Doble
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Intervention Group
Participants receive an 8-week interoception-integrated adapted mindfulness training program, in addition to routine treatment, examinations, nursing care, and health education.
|
An 8-week adapted mindfulness program, based on Mindfulness-Based Stress Reduction (MBSR), is delivered to patients with Impaired Awareness of Hypoglycemia (IAH) by a multidisciplinary team.
It involves weekly 1-1.5 hour face-to-face group sessions (8-10 participants) and daily home practices supervised via a WeChat group.
Tailored to IAH, the curriculum integrates core skills (mindful meditation, yoga, breathing, and walking) with IAH-specific elements.
By training self-awareness, attentional control, and emotional regulation, it aims to enhance interoceptive awareness.
This strengthens hypoglycemia-related perceptual behaviors, helping patients acquire self-regulation skills, attend to physical sensations of hypoglycemia, perceive nocturnal hypoglycemia, and identify fear of hypoglycemia.
|
|
Comparador activo: Control Group
Participants receive routine treatment, examinations, nursing care, and health education only, without the mindfulness training during the 8-week study period.
|
The control group receives routine medical care, examinations, nursing, and health education.
While they undergo the same follow-up schedule as the intervention group, no mindfulness practice guidance is provided during the study period.
Upon the conclusion of the study, mindfulness-related materials will be distributed to these participants.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Periodo de tiempo |
|---|---|
|
Clark Score
Periodo de tiempo: Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention
|
Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention
|
|
Gold Score
Periodo de tiempo: Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention
|
Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention
|
|
Multidimensional Assessment of Interoceptive Awareness Version 2
Periodo de tiempo: Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention
|
Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention
|
Medidas de resultado secundarias
Medida de resultado |
Periodo de tiempo |
|---|---|
|
Five Facet Mindfulness
Periodo de tiempo: Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention
|
Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention
|
|
Negative Cognitive Processing Bias Questionnaire
Periodo de tiempo: Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention
|
Baseline (T0), immediately (T1), 1 (T2) and 3 months (T3) post-intervention
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Estimado)
1 de junio de 2026
Finalización primaria (Estimado)
1 de junio de 2027
Finalización del estudio (Estimado)
1 de junio de 2027
Fechas de registro del estudio
Enviado por primera vez
8 de mayo de 2026
Primero enviado que cumplió con los criterios de control de calidad
8 de mayo de 2026
Publicado por primera vez (Actual)
14 de mayo de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
14 de mayo de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
8 de mayo de 2026
Última verificación
1 de mayo de 2026
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- YZUHL20250040
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .